Advertisement

Organisation › Details
Illumina Accelerator Cambridge UK
In July 2019 Illumina, Inc. announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the San Francisco Bay Area in 2014, Illumina Accelerator is a company creation engine focused on partnering with entrepreneurs to build breakthrough genomics startups. Illumina Accelerator is proud to open its first international location at Illumina’s Europe, Middle East and Africa (EMEA) headquarters in Cambridge, UK. The inaugural funding cycle of Illumina Accelerator Cambridge will begin in Spring 2020. During two, six-month funding cycles per year, Illumina Accelerator provides selected startups with access to seed investment, access to Illumina sequencing systems and reagents, as well as business guidance, genomics expertise, and fully operational lab space adjacent to Illumina’s campuses in Cambridge, UK or the San Francisco Bay Area. Illumina Accelerator Cambridge is partnering with several leading venture capital firms across Europe, including SV Health Investors, Sofinnova Partners, Seventure Partners, F-Prime Capital, and Illumina Ventures, to provide selected startups with hands-on company-building expertise and coaching during the six-month funding cycle in Cambridge. *
![]() |
Start | 2019-07-16 established |
Group | Illumina (Group) | |
![]() |
Industry | genomics |
Industry 2 | business park management / science park management | |
![]() |
Region | Cambridge, Cambridgeshire |
Country | United Kingdom (GB) | |
City | n. a. Cambridge, Cambridgeshire | |
Address record changed: 2019-09-27 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Illumina, Inc.. (7/16/19). "Press Release: Illumina Expands Genomics Accelerator to Cambridge, UK". San Diego, CA. | ||
Record changed: 2025-03-16 |
Advertisement

More documents for Illumina (Group)
- [1] Delfi Diagnostics, Inc.. (1/5/24). "Press Release: Delfi Diagnostics Appoints Susan Tousi as New Chief Executive Officer". Baltimore, MD & Palo Alto, CA....
- [2] Broken String Biosciences Ltd.. (9/18/23). "Press Release: Broken String Biosciences Closes $15M Series A Funding Round". Cambridge....
- [3] Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA....
- [4] Illumina, Inc.. (8/28/23). "Press Release: Illumina to Webcast Upcoming Investor Conference". San Diego, CA....
- [5] Illumina, Inc.. (8/17/23). "Press Release: Illumina Expands Genomics Capabilities in India with Opening of Solutions Center". San Diego, CA....
- [6] Illumina, Inc.. (7/18/23). "Press Release: The Alliance for Genomic Discovery Announces Founding Biopharma Members – AbbVie, Amgen, AstraZeneca, Bayer, and Merck". San Diego, CA....
- [7] Illumina, Inc.. (6/11/23). "Press Release: Illumina Announces CEO Transition Plan". San Diego, CA....
- [8] Illumina, Inc.. (10/11/22). "Press Release: Illumina Launches Strategic Research Collaboration with AstraZeneca to Accelerate Drug Target Discovery". San Diego, CA....
- [9] Illumina, Inc.. (6/28/22). "Press Release: Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health". San Diego, CA....
- [10] Illumina, Inc.. (5/5/22). "Press Release: Illumina and Deerfield Management Partner to Accelerate Drug Development". San Diego, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top